Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.
Background and Rationale:
Tricuspid regurgitation (TR) is a major health and economic burden due to high rates of heart failure hospitalizations, morbidity and mortality. Surcial treatment of TR is associated with high procedural and in-hospital mortality. Due to prohibitive surgical risk, a significant proportion of patients historically remained untreted beyond medical therapy. Transcatheter tricuspid valve (TV) repair and replacement techniques (TTVT) now offer a new treatment perspective for these patients. The EuroTR registry aims at optimizing patient selection prior to TTVT and thus treatment quality by collecting respective data in a real-world setting.
Objectives:
To investigate clinical and survival outcome following transcatheter tricuspid valve repair or replacement.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| T-TEER | Device | T-TEER using the PACAL or TriClip device |
|
| Measure | Description | Time Frame |
|---|---|---|
| All-cause mortality | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Technical success | absence of procedural mortality, successful access, delivery and retrieval of the delivery system, successful deployment and positioning, freedom from emergency surgery | 5 years |
| Procedural Safety |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Patients treated with one of the following transcatheter devices for TV repair or replacement (e.g. PASCAL, TriClip, TricValve, Evoque, LuX-Valve)
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jörg Hausleiter, Prof. Dr. | Contact | +49 89 4400 72360 | Joerg.Hausleiter@med.uni-muenchen.de | |
| Lukas Stolz, Dr. | Contact | Lukas.Stolz@med.uni-muenchen.de |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| LMU Klinikum | Recruiting | Munich | Bavaria | 81377 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41235431 | Derived | Masiero G, Arturi F, Ceni S, Panza A, Kresoja KP, von Stein J, Fortmeier V, Koell B, Rottbauer W, Kassar M, Goebel B, Denti P, Achouh P, Rassaf T, Barreiro-Perez M, Boekstegers P, Ruck A, Zdanyte M, Adamo M, Vincent F, Schlegel P, Rosch S, Wild MG, Besler C, Toggweiler S, Brunner S, Grapsa J, Patterson T, Thiele H, Kister T, Sticchi A, De Carlo M, Voss F, Polzin A, Popolo Rubbio A, Bedogni F, Stolte T, Nestelberger T, Benito-Gonzalez T, Sanchez-Munoz E, Konstandin MH, Van Belle E, Metra M, Geisler T, Estevez-Loureiro R, Mahabadi AA, Karam N, Maisano F, Lauten P, Praz F, Kessler M, Kalbacher D, Rudolph V, Iliadis C, Lurz P, Hausleiter J, Stolz L, Tarantini G; EuroTR Investigators. Invasive Hemodynamics and Risk Stratification in T-TEER: Moving Beyond ESC Thresholds - EuroTR Registry Insights. Circ Cardiovasc Interv. 2026 Jan;19(1):e015964. doi: 10.1161/CIRCINTERVENTIONS.125.015964. Epub 2025 Nov 14. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014262 | Tricuspid Valve Insufficiency |
| D006349 | Heart Valve Diseases |
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
periprocedural and in-hospital adverse events
| 5 years |
| Heart Failure Biomarker | NT-proBNP level | 5 years |
| Dyspnea on exertion | New York Heart Association (NYHA) functional class | 5 years |
| Functional capacity | 6-minute walk distance (6MWD) | 5 years |
| Right ventricular size | Mid-ventricular diameter of the right ventricle measured by echocardiography | 5 years |
| Right ventricular function | Right ventricular fractional area change measured by echocardiography | 5 years |
| Tricuspid regurgitation reduction | Tricuspid regurgitation severity measured by echocardiography | 5 years |
| Tricuspid valve stenosis | Transvalvular pressure gradient measured by echocardiography | 5 years |
| Pulmonary hypertension | Pulmonary artery pressure measured by echocardiography | 5 years |
| Right heart congestion | Inferior vena cava dimensions measured by echocardiography | 5 years |
| Hospitalization for heart failure | Date and number of heart failure hospitalizations after the index procedure | 5 years |